Family Medicine · Bronx, NY
NPI
1497824619
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1400 Pelham Pkwy S, Bld 1 4 NW
Bronx, NY, 10461
Phone (718) 918-5747
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$515K
4,703 prescriptions
Company payments, 2025
$398
From 1 companies
Medicare prescription drug claims, 2024
In 2024, the drug Evia Alikaj Nano prescribed most often to Medicare patients was Atorvastatin Calcium, with 275 prescriptions and refills. In total Evia Alikaj Nano wrote 4,703 Medicare prescriptions that cost $515K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-12-11.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 275 | 625 | 70 | $1,737 |
| Simvastatin Generic | 186 | 403 | 44 | $624 |
| Metformin Hcl Generic | 183 | 383 | 42 | $792 |
| Omeprazole Generic | 164 | 324 | 38 | $1,349 |
| Tamsulosin Hcl Generic | 161 | 290 | 34 | $1,524 |
| Ozempic Semaglutide | 151 | 186 | 23 | $166K |
| Famotidine Generic | 149 | 243 | 33 | $1,266 |
| Amlodipine Besylate Generic | 146 | 328 | 37 | $560 |
| Losartan Potassium Generic | 135 | 301 | 36 | $813 |
| Hydrochlorothiazide Generic | 122 | 304 | 31 | $343 |
| Diclofenac Sodium Generic | 121 | 134 | 26 | $4,660 |
| Lisinopril Generic | 121 | 281 | 36 | $441 |
| Donepezil Hcl Generic | 98 | 178 | 22 | $511 |
| Metoprolol Succinate Generic | 96 | 242 | 29 | $1,500 |
| Alcohol Prep Pads Alcohol Antiseptic Pads | 92 | 132 | 25 | $349 |
Brand drugs: 719 claims; generic drugs: 3,784 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Evia Alikaj Nano $398 ($398 in general payments such as food, travel and fees) from 1 company. The largest payer was Revance Therapeutics, Inc. with $398.
| Company | Payments | Amount |
|---|---|---|
| Revance Therapeutics, Inc. | 4 | $398 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.